Above Food Files Appeal to NASDAQ and Initiates Path to Relisting

Above Food’s NASDAQ relisting hopes are all talk—no numbers, no proof, just promises.

What the company is saying

Above Food Ingredients Inc. is telling investors that it has formally appealed a NASDAQ delisting determination and expects to relist on the NASDAQ Exchange. The company frames itself as a committed, innovative agricultural and food technology player, emphasizing a vision to 'create a healthier world' and 'break the cycle of world hunger.' Management highlights proprietary seed development, AI-driven genomics, and a partnership with Palm Global as transformative, suggesting these will deliver global impact. The announcement is heavy on forward-looking statements, repeatedly referencing expected regulatory approvals, audit completions, and the successful merger with Palm Global. The language is aspirational and confidence-driven, but avoids specifics—there are no operational milestones, financial results, or concrete timelines disclosed. The press release foregrounds the appeal process and the company’s commitment to compliance, but buries the fact that all major positive outcomes are contingent on future events. There is also a legalistic tone, with disclaimers about forward-looking information and references to potential liabilities, such as a termination fee if the merger fails. No notable individuals or institutional investors are named, and the communication style is generic, lacking any personal accountability or leadership visibility. This narrative fits a classic playbook for companies in regulatory limbo: reassure investors with big visions and future plans, while providing minimal hard evidence or realised progress.

What the data suggests

The only concrete, realised data in the announcement is that Above Food has submitted an appeal to the NASDAQ delisting determination and will continue to trade on the OTC Market during the review. There are no disclosed financial results, revenue figures, profit/loss numbers, cash flow statements, or balance sheet data. No operational metrics, such as production volumes, customer wins, or technology deployments, are provided. The company does not report on whether it has met any prior targets or guidance, nor does it reference any historical performance. The gap between what is claimed—relating to relisting, technological impact, and merger synergies—and what is evidenced is vast: all positive outcomes are hypothetical and unsupported by numbers. The quality of disclosure is poor for financial analysis, as key metrics are missing and there is no way to assess the company’s financial health, liquidity, or operational momentum. An independent analyst, looking only at the numbers (or lack thereof), would conclude that there is no basis for evaluating the company’s trajectory or credibility. The only verifiable fact is the regulatory appeal; everything else is speculative.

Analysis

The announcement is primarily a regulatory update about the submission of an appeal to the NASDAQ delisting determination, which is a factual, realised event. However, the majority of the claims in the release are forward-looking, including expectations to relist on NASDAQ, the completion of audits, regulatory approvals, and the successful merger with Palm Global. These are all contingent on future events with no disclosed binding agreements or completed milestones. The language around the company's vision and the transformative impact of its technology is aspirational and unsupported by any measurable data in the text. There is no disclosure of financial results, operational progress, or concrete timelines for benefit realisation. While there is mention of a potential termination fee, no large capital outlay is disclosed as already committed. The gap between narrative and evidence is moderate, with the realised progress limited to the appeal submission and continued OTC trading.

Risk flags

• ●Regulatory risk is high: the company is appealing a NASDAQ delisting, and there is no guarantee the appeal will succeed. If the relisting fails, Above Food will remain on the OTC Market, which typically offers lower liquidity and visibility for investors.
• ●Disclosure risk is acute: the announcement contains no financial statements, operational metrics, or quantitative data. This lack of transparency makes it impossible for investors to assess the company’s financial health or performance trajectory.
• ●Execution risk is substantial: all major positive outcomes—relisting, merger completion, regulatory approvals—are forward-looking and contingent on multiple external parties and processes. Any delay or failure in these steps could materially impact the company’s prospects.
• ●Capital intensity and liability risk: the company may be liable for a termination fee to Palm Global if the merger is not completed. The size and terms of this fee are undisclosed, creating uncertainty about potential cash outflows.
• ●Narrative-evidence gap: the company’s claims about technological impact, global hunger, and AI-driven genomics are unsupported by any operational or financial data. This pattern of aspirational language without substance is a classic red flag for hype.
• ●Timeline risk: with no disclosed deadlines or progress milestones, investors face the risk of indefinite delays. The company’s history of forward-looking statements without realised outcomes suggests that timelines may slip or never materialise.
• ●Pattern risk: the announcement fits a familiar pattern for companies in regulatory or financial distress—emphasising future potential while providing no evidence of current strength. This should make investors cautious about taking management’s narrative at face value.
• ●Geographic and jurisdictional complexity: the company operates across the United States and Canada, and references regulatory filings in both jurisdictions. This adds layers of legal and compliance risk, especially given the cross-border nature of the proposed merger.

Bottom line

For investors, this announcement is a regulatory update with little practical value beyond confirming that Above Food Ingredients Inc. is fighting to avoid a NASDAQ delisting. The company’s narrative is long on vision and future plans, but short on evidence—there are no financials, no operational milestones, and no concrete progress toward relisting or merger completion. The absence of any notable institutional investors or named executives further weakens the credibility of the story. If the company wants to change this assessment, it needs to disclose realised milestones: completed audits, signed merger agreements, confirmed regulatory approvals, and—most importantly—quantitative financial and operational data. In the next reporting period, investors should watch for actual filings (such as the Annual Report on Form 20-F), evidence of NASDAQ relisting, and any binding agreements with Palm Global. Until then, this announcement is best viewed as a signal to monitor, not to act on. The most important takeaway is that all the upside is hypothetical and distant, while the risks—regulatory, disclosure, and execution—are immediate and real. Investors should demand hard evidence before committing capital.

Announcement summary

(OTC: ABVEF) Above Food Ingredients Inc. announced that it has submitted an appeal to the NASDAQ delisting determination in accordance with Nasdaq Listing Rule 5820(a). The Company expects to relist on the NASDAQ Exchange and remains committed to meeting and maintaining all listing requirements. In the interim, the Company will continue to trade on the OTC Market while the NASDAQ Hearing and Review Council completes its review of the appeal submission. The press release states that the expected timing of the completion of the audit and the filing of the Company's Annual Report on Form 20-F, the successful filing of a prospectus in Canada, and the expected trading of the combined company on the Nasdaq are forward-looking statements. The company also references a proposed transaction with Palm Global, including the satisfaction or waiver of all the required conditions thereto and the expected timing of regulatory approvals. Above Food may be liable to pay a termination fee to Palm Global if the Merger is terminated, subject to the precise terms of the Merger Agreement. Investors and security holders are urged to read the documents filed with the SEC, which will contain important information about Above Food.

Disagree with this article?